How to Save Money on Kevzara in 2026: Coupons, Discounts, and Patient Assistance

Kevzara (sarilumab) is one of the most effective biologics available for rheumatoid arthritis and polymyalgia rheumatica—but its list price can be staggering. With no generic or biosimilar available in 2026, a standard 2-syringe carton (28-day supply) costs approximately $4,774–$5,555 at retail. Annually, that's well over $100,000. The good news: most patients pay far less, thanks to insurance and manufacturer savings programs. Here's everything you need to know about how to afford Kevzara in 2026.

What Does Kevzara Actually Cost Out of Pocket?

What you actually pay for Kevzara depends on your insurance situation:

Without insurance: List price of approximately $4,774–$5,555 per 28-day supply (2 syringes), or over $100,000 per year.

With commercial insurance: Typically placed on a Specialty Tier (Tier 4 or 5), meaning a copay of $150–$500 or more per fill before any savings programs are applied.

With KevzaraConnect copay card (commercially insured): As low as $0/month, up to $15,000/year in assistance (not valid for Medicare or Medicaid).

With Medicare (Part D): Specialty tier copays can range from $100–$400+ per fill depending on your plan and the coverage gap; manufacturer copay cards cannot be used with Medicare, but patient assistance programs may be available.

KevzaraConnect Copay Card: The #1 Savings Tool for Insured Patients

The KevzaraConnect Copay Card is Sanofi's manufacturer savings program for commercially insured patients. Here are the key details:

Eligible patients may pay as little as $0 per month for Kevzara

Maximum annual benefit: $15,000 per calendar year

Available to patients with commercial insurance (employer-sponsored, ACA marketplace, or private plans)

NOT valid for Medicare, Medicaid, VA, TRICARE, or other government-funded insurance

To enroll: call 1-844-538-9272 or visit kevzara.com/starting-kevzara/kevzaraconnect-copay-card

KevzaraConnect Patient Assistance Program: For Uninsured and Underinsured Patients

For patients who are uninsured or underinsured and cannot afford Kevzara, Sanofi's patient assistance program (PAP) through KevzaraConnect may provide the medication at no cost. Eligibility is generally based on income and insurance status. Requirements typically include:

US resident with a valid Kevzara prescription for an FDA-approved indication

Uninsured, functionally uninsured, or enrolled in Medicare/Medicaid but unable to afford required cost share

Meet income eligibility criteria (varies by program; family size is considered)

To apply: call KevzaraConnect at 1-844-538-9272 or visit the KevzaraConnect section at kevzara.com. Your rheumatologist's office can assist with the application.

Free 30-Day Trial Supply from Sanofi

New patients starting Kevzara can receive a one-time, 30-day free trial supply through TheraCom specialty pharmacy while waiting for insurance prior authorization to be approved. This is separate from the copay card program and helps patients avoid a gap in therapy at initiation. Your doctor must fax a completed KevzaraConnect voucher form and a 30-day prescription to TheraCom to initiate this.

Medicare Patients: What Are Your Options?

Medicare patients cannot use the KevzaraConnect copay card (this is a federal regulatory requirement that applies to all manufacturer copay programs for Medicare Part D drugs). However, Medicare patients on Kevzara have some options:

KevzaraConnect Patient Assistance Program: Uninsured or functionally uninsured Medicare patients who meet income criteria may qualify for free Kevzara.

Extra Help / Low Income Subsidy (LIS): Federal program that may reduce or eliminate Medicare Part D cost share for eligible low-income beneficiaries. Apply at SSA.gov.

Medicare Prescription Payment Plan (2025+): Allows spreading out-of-pocket Part D costs across the year rather than paying in a lump sum at the start of the benefit year.

Prescription Hope: A third-party patient advocacy program that works with pharmaceutical manufacturers and may be able to obtain Kevzara for a set monthly fee of around $70 for eligible patients.

Insurance Tips That Can Reduce Your Kevzara Costs

Appeal denied prior authorizations. Many initial PA denials are overturned on appeal—particularly when your rheumatologist submits a detailed letter of medical necessity explaining why Kevzara specifically is the most appropriate therapy.

Request an exceptions process. If your plan's formulary doesn't cover Kevzara, you can formally request an exception if other formulary options have failed or are medically inappropriate.

Compare plans during open enrollment. Insurance plans that include Kevzara as a covered specialty tier drug will dramatically reduce your annual cost. Use the plan's formulary lookup to confirm Kevzara coverage before enrolling.

The Bottom Line on Kevzara Costs in 2026

Kevzara's list price is high, but with the right combination of insurance coverage and manufacturer savings programs, most commercially insured patients can access it for $0/month through KevzaraConnect. Uninsured and Medicare patients have more limited but still meaningful options through the PAP and Extra Help programs. If you're struggling to find Kevzara at a specialty pharmacy near you in addition to cost issues, medfinder can help you locate which pharmacies can fill your prescription.